dot
a brand of Pharmaquinone
logo
Menu:
Product Overview
Essential details
Product name
Vitaquinone®0.15% MCT Oil Vitamin K2 as MK-7
SKU code
V015L
Chemical names
Menaquinone-7 (MK-7)
Common name
Vitamin K2
General product information
Synthetic Vitamin K2 as MK-7 in MCT oil for use in food and dietary supplements
Country of origin
Poland
Manufacturer
Vitasynth
Dilution site
Europharma Alliance, Poland
Sample
Available
Our certificates
FDA logotype
halal logotype
Delivery
Packaging & labelling
Aluminum, silver bottle, with white closure with warranty ring and LDPE/ALU/LDPE wad, which is co-packed in the aluminum-based and appropriate labeled doypack packaging.
Storage conditions
The packaged product should be stored at 15-25°C / 59-77°F. Protect from light and excessive heat. The product is very light sensitive and exposure may deteriorate K2 activity considerably. Avoid excessive humidity.
Batch/lot numbering system
V015L2310-1
V015L - the product SKU code
yy.mm - the date format
1st batch of the month
Label information
Product name and SKU code
Batch no., manufacturing date & best before
Handling precautions
VitaSynth contact information
Icons identifying certifications such as Kosher or Halal status
Recommended restriction / Market specific labelling is implemented where required limitation on finished product label
Market specific labelling is implemented where required. Vitamin K2 may counteract the effects of anticoagulation therapy, and therefore is not recommended for patients on blood-thinning medications. The maximal daily dose in food supplement of 0.2 mg should not be exceeded
Up to 300kg
DHL logo
Above 301kg
db schenker
Download all documents
Download package of our documents about this product
Download separate files:
1. Product Information Data Sheet

Click to see online safe pdf

2. Certificate of analysis

Click to see online safe pdf

3. Product specification

Click to see online safe pdf

4. Vitaquinone Leaflet

Click to see online safe pdf

Sample Certificate of Analysis
Tests
Requirements
Results
Appearance
Light yellow to yellow oil
-
Identification
Corresponds to the standard HPLC profile
-
Total Vitamin K2 as MK-7 (as-is)
> 0.15 % or > 1500 ppm
-
Related substances
Total impurities
Not more than 1.50%
-
Isomeric purity
Content of cis-menaquinone-7
≤ 1.50%
-
Density (in 20˚C)
0.944 +/- 1.44% g/ml
-
Water solubility
Insoluble
-
Heavy metals
Arsenic

Cadmium

Lead

Mercury

≤ 0.5 ppm

≤ 0.3 ppm

≤ 0.5 ppm

≤ 0.1 ppm

-

-

-

-
Microbiological parameters
TAMC in 1g

TYMC in 1g

E. Coli in 1g

Salmonella in 25 g

Staphylococcus aureus in 1g

Bile tolerant gram negative bacteria**in 1g

≤ 1 x 103 CFU

≤ 1 x 102 CFU

Absent

Absent

Absent

≤ 1 x 102 CFU

-

-

-

-

-

-
Product Information Data Sheet

Vitaquinone®0.15% MCT Oil Vitamin K2 as MK-7

1. Product Identity and Form
Product name
Vitaquinone®0.15% MCT Oil Vitamin K2 as MK-7
SKU code
V015L
Chemical names
Menaquinone-7 (MK-7)
Common name
Vitamin K2
General product information
Synthetic Vitamin K2 as MK-7 in MCT oil for use in food and dietary supplements
Country of origin
Poland
2. Responsible for Product Development, Research and Regulatory Affairs
Product developer, marketing responsible IPR holder and regulatory affairs
VitaSynth Sp. z o. o.
Office and postal address
2 Szałwiowa Street 03-167 Warsaw Poland
Telephone
+48 22 602 22 29
Info
sales@pharmaquinone.com
Web
www.pharmaquinone.com
Country of origin
Poland
3. Manufacturing and Quality Assurance/Quality Control Information
QA/QC and control Manufacturer
VitaSynth is responsible for Vitamin K2 quality and control EuroPharma Alliance, ul. Al. LED 1, 55-020 Rzeplin, Poland (sister company of VitaSynth, CMO facility)
Manufacturing process
Pure K2 vitamin is mixed with MCT oil in a prolonged process and controlled heating. The oil obtained in the process is further mixed with MCT oil to a given concentration
Manufacturing flow chart
See section 14
Quality Assurance Systems
See section 5 for details.
Certificates available upon request
Residual solvent in accordance
See section 6 for details
Irradiation or chemical sterilization
No irradiation or chemical sterilization is used during production. See section 6 Regulatory Status
Traceability system for product identity
In place
SDS
See section 15
Last revision of QA/QC systems
2023
4. Lot Number System, Product Storage, Packaging and Labelling Information
Packaging and labelling
Aluminum, silver bottle, with white closure with warranty ring and LDPE/ALU/LDPE wad, which is co-packed in the aluminum-based and appropriate labeled doypack packaging
Storage conditions
The packaged product should be stored at 15-25°C / 59-77°F. Protect from light and excessive heat. The product is very light sensitive and exposure may deteriorate K2 activity considerably. Avoid excessive humidity.
Batch/lot numbering system
V015L2310-1
V015L - the product SKU code
yy.mm - the date format
1st batch of the month
Label information
Product name and SKU code
Batch no., manufacturing date & best before
Handling precautions
VitaSynth contact information
Icons identifying certifications such as Kosher or Halal status
Recommended restriction / limitation on finished product label
Market specific labelling is implemented where required. Vitamin K2 may counteract the effects of anticoagulation therapy, and therefore is not recommended for patients on blood-thinning medications. The maximal daily dose in food supplement of 0.2 mg should not be exceeded
5. Certifications and Compliance
Certification
Status
Third party
Expiry
Kosher
Certified
EarthKosher
18.08.2024
Halal
Certified
HFCE
31.01.2024
Vegan
Certified
Vegan Society
20.06.2024
FDA
Statement*
NA
NA
cGMP
Statement*
NA
NA
HACCP
Certified
TÜV Rheinland
03.01.2026
ISO (FSSC22000)
Certified
TÜV Rheinland
03.01.2026
Non-GMO
Statement*
NA
NA
USDA Organic
Certified
Bioagricert
06.09.2024
* See section 16
6. Regulatory Status and IPR

Compliance with Regulations
Pharmaquinone® Products are identical to already authorised under Regulation 258/1997/EC novel foods and these authorizations are not data protected according to the requirements of Article 26 of Regulation EU 20015/2283. Therefore Pharmaquinone® Products have been placed in the EU market without a dedicated application. The specifications and conditions of use of Pharmaquinone® Productsare in line with the authorised specifications and conditions of use as set out in the Union list of authorised novel foods and/or the implementing Regulations authorizing these substances in accordance to COMMISSION IMPLEMENTING REGULATION (EU) 2018/1023 of 23 July 2018 correcting Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods.

Compliance to Regulations in Europe and the US
GMO
Complies with EU Regulation No 1829/2003, including amended EU Directive 2001/18/EC
Ionizing radiation
Complies with EU Directive 1999/2/EC.Product has not been sterilized
Contaminants/toxins
Complies with Regulation (EC) No. 1881/2006 setting maximum levels for certain contaminants in food stuffs and amendments as per(EC) No 629/2008 of 2 July 2008
Pesticides
Complies with EU Regulations (EC) No 396/2005, including amended EU Directive 91/414/EEC
Residual Solvents
Complies with good manufacturing practice, EU Directive 2009/32/EC and Ph. Eur. p. 2.4.24 / USP <467> Residual Solvents requirements
BSE/TSE*
Complies with good manufacturing practice and EU Regulation (EC)No 999/2001.
Prop 65
Does not contain compounds listed in California Proposition 65
Nano material
No nano material substances as per definition of EU REG.1169/2011
WADA
Do not contain any substances included in the prohibited list of the World Anti-Doping Agency (WADA)
* See section 16
Stability Protocol

Stability program follows ICH Guideline to meet market specific requirements.

Intellectual Property Rights/Patents Granted/Patent Pending

To whom it may concern,

To the best of our knowledge, the Product Pharmaquinone®, Vitamin K2 as MK-7 does not infringe any patent rights, rights in inventions, copyright and related rights in information (including protected know-how, confidentiality and trade secrets) (“IPRs”), belonging to a third party based on the comprehensive overview of the patents‘ situation (granted and pending) in Europe.
Yours faithfully,

Name: Elżbieta Filutowska
Designation: Quality Department

Tariff Code, FDA Registration and Compendial Standard
EU export tariff code
2936 29 00 00
US import tariff code
2936 29 50 50
U.S. FDA Registration VitaSynth No.
18752137180
DUNS VitaSynth No.
425446420
Compendial standard
USP monograph for menaquinone-7and in-house methods
7. Food Safety System

To whom it may concern,

Pharmaquinone® Product, Vitamin K2 as MK-7 is a generic of the well-established and safe for human consumption original active ingredient, which has achieved GRAS in USA and novel food status in EU.The product is intended for use in the manufacturing of food products, including food supplements. Our process ensures the best quality and accordance to European novel food specification, being accepted by the Health Authorities as a reference for the manufacturers.
Yours faithfully,

Name: Elżbieta Filutowska
Designation: Quality Department

8. Origin and Composition
Name ingredient
CAS
1500ppm
Origin
GMO status
Menaquinone-7
2124-57-4
0.15%
Chemical synthesis
non-GMO
Medium chain triglyceride oil (MCT)*
73398-61-5
99.85%
Vegetable origin
non-GMO
* 100% MCT Oil coconut based, organic
9. Nutritional Profile*
Component
Typical value per 100 g
Total calories
679 Kcal
Total proteins
0.00 g
Total fat
99.85 g
Dietary fiber
0.00 g
Total sugars
0.00 g
Carbohydrates
0.00 g
Salt
0.00 g
Vitamin K2 as MK7
1500 ppm
* Based on theoretical calculations
10. Allergens on Production Line

Free from allergens in compliance with EU Directive 1169/2011 Annex II

Raw material/allergen
Presence in Pharmaquinone® Product
Presence on production line for other products
Cereals containing gluten1 and products thereof
No
Yes
Crustaceans and products thereof
No
Yes
Eggs and products thereof
No
No
Fish and products thereof
No
Yes
Peanuts and products thereof
No
No
Soybeans and products thereof
No
Yes
Milk and products thereof (including lactose)
No
Yes
Nuts2 and products thereof
No
No
Celery and products thereof
No
No
Mustard and products thereof
No
No
Sesame seeds and products thereof
No
No
Sulphur dioxide and sulphites3
No
Yes
Lupin and products thereof
No
No
Molluscs and products thereof
No
Yes
11. Free from Allergen Statement

To whom it may concern,

In compliance with EU Directive 1169/2011 Annex II
1. Cereals containing gluten
2. Crustaceans and products thereof
3. Eggs and products thereof
4. Fish and products thereof
5. Peanuts and products thereof
6. Soybeans and products thereof
7. Milk and products thereof (including lactose)
8. Nuts and products thereof
9. Celery and products thereof
10. Mustard and products thereof
11. Sesame seeds and products thereof
12. Sulphur dioxide and sulphites at concentrations of more than 10 mg/kg or 10 mg/liter expressed as SO2
13. Lupin and products thereof
14. Molluscs and products thereof

Your faithfully,
Name: Elżbieta Filutowska
Designation: Quality Department

12. Product Specification
Product name
Vitaquinone® 0.15% MCT Oil
Vitamin K2 as MK-7
SKU codes
V015L
Vitamin K2 content
NLT 1500 mg K2 as MK-7/g
Packaging
1 kg or 5 kg of Product in aluminium bottle with tamper evident PP screw cap closure withfoam/aluminium liner and LDPE plug
Tests
Requirements
Method
Appearance
Light yellow to yellow oil
Visual assessment
Identification
Corresponds to the standard HPLC profile
UPLC method* /
USP <621>
Total Vitamin K2 as MK-7
> 0.15 % or > 1500 ppm
UPLC method*
Related substances Total impurities
Not more than 1.50%
UPLC method*
Isomeric purity Content of cis-menaquinone-7
≤ 1.50%
USP <621>
Density (in 20˚C)
0.944 +/- 1.44% g/ml
PN-EN ISO 6883:2017-03
Water solubility
Insoluble
Ph. Eur. <General notices / USP <General notices>
Weight tolerance limit
Not less than 100% of the declaredweight
Each unit container is weighed Sampling/emptying allowance is added to each unit container
Uniformity of mix
All samples must pass assay test
n + 1 unit containers are drawn from each production batch
Heavy metals
Arsenic***

Cadmium***

Lead***

Mercury***

≤ 0.5 ppm

≤ 0.3 ppm

≤ 0.5 ppm

≤ 0.1 ppm

Ph. Eur. <2.2.58> / USP <233>
Ph. Eur. <2.2.58> / USP <233>
Ph. Eur. <2.2.58> / USP <233>
Ph. Eur. <2.2.58> / USP <233>
Microbiological parameters
TAMC in 1g

TYMC in 1g

E. Coli in 1g

Salmonella in 25 g

Staphylococcus aureus in 1g
Bile tolerant gram negative bacteria**in 1g

≤ 1 x 103 CFU

≤ 1 x 102 CFU

Absent

Absent

Absent

≤ 1 x 102 CFU

Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.13> / USP <2022>
Ph. Eur. <2.6.13> / USP <2022>
Ph. Eur. <2.6.13> / USP <2022>
Ph. Eur. <2.6.13> / USP <2021>

* <A novel method for the determination of chemical purity and assay of menaquinone-7. Comparison with the methods from the official USP monograph> by Jedynak et al.
** BILE TOLERANT GRAM NEGATIVE BACTERIA INCLIDE ENTEROBACTERIACEAE, PSEUDOMONAS AND AEROMONAS
*** EVERY THIRD BATCH IS TESTED

Shelf life, storage and handling

30 months of date of production. The packed Product should be stored in temperature. Protect from the light.
The product is very light sensitive and exposure may deteriorate K2 activity

The only „Single peak” vitamin K2
13. Certificate of Analysis
Product name
Vitaquinone® 0.15% MCT Oil
Vitamin K2 as MK-7
SKU codes
V015L
Batch number
-
Best before
30 months from manufacture
Manufacturing date
-
Expiry date
-
Storage
The packed product should be stored in temperature. Protect from light
Packaging
An alluminium bottle
Tests
Requirements
Results
Appearance
Light yellow to yellow oil
Complies
Identification
Corresponds to the standard HPLC profile
Complies
Total Vitamin K2 as MK-7 (UPLC Method*)
> 0.15 % or > 1500 ppm
-
Related substances (UPLC Method*) Total impurities
Not more than 1.50%
-
Isomeric purity (UPLC Method) Content of cis-menaquinone-7
≤ 1.50%
-
Density (in 20˚C)
0.944 +/- 1.44% g/ml
-
Water solubility
Insoluble
-
Heavy metals
Arsenic

Cadmium

Lead

Mercury

≤ 0.5 ppm

≤ 0.3 ppm

≤ 0.5 ppm

≤ 0.1 ppm
-
Microbiological parameters
TAMC in 1g

TYMC in 1g

E. Coli in 1g

Salmonella in 25 g

Staphylococcus aureus in 1g
Bile tolerant gram negative bacteria**in 1g

≤ 1 x 103 CFU

≤ 1 x 102 CFU

Absent

Absent

Absent

≤ 1 x 102 CFU
-

* <A novel method for the determination of chemical purity and assay of menaquinone-7. Comparison with the methods from the official USP monograph> by Jedynak et al.
** BILE TOLERANT GRAM NEGATIVE BACTERIA INCLIDE ENTEROBACTERIACEAE, PSEUDOMONAS AND AEROMONAS

14. Flowchart
15. Safety Data Sheet
1. Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name
Vitaquinone®0.15% MCT Oil Vitamin K2 as MK-7
Product Number
V015L
Brand
VitaSynth Sp. z o. o.
Recommended use
Food, dietary supplements
Identified uses
The manufacturing of food products, including food supplements, havebeen Generally Recognized as Safe (self-affirmed GRAS), meaning that they are safe for human consumption. In the European Union Pharmaquinone products are recognized as Generic Novel Foods.
Details of the supplier of the safety data sheet
Company
VitaSynth Sp. z o. o.
2 Szałwiowa Street
PL- 03-167 Warsaw
Telephone
+48 22 602 22 29
E-mail address
sales@pharmaquinone.com
Emergency telephone
Emergency Phone
+(48)-223988029 (CHEMTREC)
998 (fire department)
112 (emergency call center)
2. Hazards identification
Classification of the substance or mixture
For the classification of the mixture the following methods have been applied: extrapolation on theconcentration levels of the hazardous substances, on basis of test results and after evaluation ofexperts. The methodologies used are mentioned at the respective test results.According to Regulation (EC) No 1272/2008 [CLP]No need for classification according to GHS criteria for this product.
Label elements
According to Regulation (EC) No 1272/2008 [CLP]The product does not require a hazard warning label in accordance with GHS criteria
Other hazards
According to Regulation (EC) No 1272/2008 [CLP]High risk of slipping due to leakage/spillage of product.VitaSynth Sp. z o. o. 2 Szałwiowa St., 03-167 Warsaw, Poland VAT# PL6772335293P a g e | 18Product does not contain a substance above legal limits included in the list established in accordancewith Article 59(1) of Regulation (EC) No 1907/2006 for having endocrine disrupting properties or isidentified to have endocrine disrupting properties in accordance with the criteria set out in CommissionDelegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605. The product doesnot fulfill the criteria for PBT (Persistent/bioaccumulative/toxic) and vPvB (very persistent/verybioaccumulative)
3. Composition/information on ingredients
Name ingredient
CAS
concetration
Menaquinone-7
2124-57-4
0.15%
Medium chain triglyceride oil (MCT)
73398-61-5
99.85%

No components need to be disclosed according to the applicable regulations.

4. First aid measures
Description of first-aid measures
Inhalation
Move to fresh air. Call a physician if symptoms develop or persist.
Skin contact
Wash off with soap and water. Get medical attention if irritation developsand persists.
Eye contact
Rinse with water. Get medical attention if irritation develops and persists
Ingestion
Persons receiving anticoagulant therapy, like warfarin or coumarins,should notify their physician. Product contains vitamin K which interfereswith the biological activity of some anticoagulants.
General information
In all cases of doubt, or when symptoms persist, seek medical advice.
Most important symptoms and effects, both acute and delayed

Symptoms: (Further) symptoms and / or effects are not known so far.

Indication of any immediate medical attention and special treatment needed

Treatment: Symptomatic treatment (decontamination, vital functions).

5. Firefighting measures
Extinguishing media

Suitable extinguishing media: water spray, carbon dioxide, dry powder, foam.Unsuitable extinguishing media for safety reasons: water jet .

Special hazards arising from the substance or mixture

Endangering substances: carbon oxides, harmful vapours.Advice: The substances/groups of substances mentioned can be released in case of fire.

Advice for firefighters

Special protective equipment:Wear a self-contained breathing apparatus.

Further information

Do not spray water directly on fire, product will float and could be reignited on surface of water. Disposeof fire debris and contaminated extinguishing water in accordance with official regulations. Coolendangered containers with water-spray.

6. Accidental release measures
Personal precautions, protective equipment and emergency procedures

Use personal protective clothing. Information regarding personal protective measures, see section 8.Ensure adequate ventilation. Avoid contact with the skin, eyes and clothing.

Environmental precautions

Do not discharge into drains/surface waters/groundwater. Inform authorities in the event of productspillage to water courses or sewage systems.

Methods and materials for containment and cleaning up

For small amounts: Contain with absorbent material (e.g. sand, silica gel, acid binder, general purposebinder, sawdust).For large amounts: Dike spillage. Pump off product.Dispose of absorbed material in accordance with regulations.

Reference to other sections

Information regarding exposure controls/personal protection and disposal considerations can befound in section 8 and 13.

7. Handling and storage
Precautions for safe handling

Handle in accordance with good industrial hygiene and safety practice.Protection against fire and explosion:
Avoid all sources of ignition: heat, sparks, open flame. Take precautionary measures against staticdischarges.

Conditions for safe storage, including any incompatibilities

Keep container tightly closed, may be stored in temperatures between 15 °C and 25 °C (RH: 30-50%).Further information on storage conditions: Protect from the effects of light.Storage class according to TRGS 510 (originally VCI, Germany): (10) Combustible liquids.

Specific end use(s)

For the relevant identified use(s) listed in Section 1 the advice mentioned in this section 7 is to beobserved.

8. Exposure controls/personal protection
Specific end use(s)
Occupational exposure limits
No exposure limits noted for ingredient(s).
Biological limit values
No biological exposure limits noted for the ingredient(s)
Engineering controls
Good general ventilation should be used. Ventilation rates should be matched to conditions. Ensure adequate ventilation, especially in confined areas.
Individual protection measures, such as personal protective equipment
Eye/face protection
If contact is likely, safety glasses with side shields are recommended
Hand and skin protection
For prolonged or repeated skin contact use suitable protective gloves. Other Wear suitable protective clothing.
Respiratory protection
In case of insufficient ventilation, wear suitable respiratory equipment.
Thermal hazard
Wear appropriate thermal protective clothing, when necessary.
General hygiene considerations

Handle in accordance with good industrial hygiene and safety practice. Wearing of closed work clothingis recommended. No eating, drinking, smoking or tobacco use at the place of work. Hands and/or faceshould be washed before breaks and at the end of the shift. Store work clothing separately.

9. Physical and chemical properties
Information on basic physical and chemical properties
Appearance Form
Light yellow to yellow oil
Odor
No data available
Odor Threshold
No data available
pH
No data available
Melting point/freezing point
~23 °F (-5 °C)
Initial boiling point and boiling range
No data available
Flash point
~500.0 °F (260.0 °C) Pensky-Martens Closed Cup
Evaporation rate
No data available
Flammability (solid, gas)
No data available
Upper/lower flammability or explosive limit
No data available
Vapor pressure
No data available
Vapor density
No data available
Density (in 20˚C)
0.944 +/- 1.44% g/ml
Water solubility
Insoluble
Partition coefficient n-octanol/water
No data available
Auto-ignition temperature
No data available
Decomposition temperature
No data available
Viscosity
No data available
Explosive properties
No data available
Auto-ignition temperature
No data available
10. Stability and reactivity
Reactivity

No hazardous reactions if stored and handled as prescribed/indicated.
Corrosion to metals: Corrosive effects to metal are not anticipated

Chemical stability

The product is stable if stored and handled as prescribed/indicated.

Possibility of hazardous reactions

No dangerous reaction known under conditions of normal use.

Conditions to avoid

Protect from light. Avoid all sources of ignition: heat, sparks, open flame.

Incompatible materials

Strong oxidizing agents. This product may react with strong alkalies.

Hazardous decomposition products

No hazardous decomposition products if stored and handled as prescribed/indicated.

11. Toxicological information
Information on toxicological effects
Acute toxicity
Virtually nontoxic after a single ingestion. Virtually nontoxic after a single skin contact. Virtuallynontoxic by inhalation.
Irritation
Not irritating to the skin. Not irritating to the eyes.
Respiratory/Skin sensitization
Based on available data, the classification criteria are not met.
Germ cell mutagenicity
Based on the ingredients, there is no suspicion of a mutagenic effect.
Carcinogenicity
Based on available data, the classification criteria are not met.
Reproductive toxicity
Based on the ingredients, there is no suspicion of a toxic effect on reproduction.
Developmental toxicity
Based on the ingredients, there is no suspicion of a teratogenic effect.
Specific target organ toxicity (single exposure)
Based on the available information there is no specific target organ toxicity to be expected after asingle exposure.
Repeated dose toxicity and Specific target organ toxicity (repeated exposure)
Based on available data, the classification criteria are not met.
Aspiration hazard
No data available.
Interactive effects
No data available.
Endocrine disrupting properties
Product does not contain a substance above legal limits included in the list established in accordancewith Article 59(1) of Regulation (EC) No 1907/2006 for having endocrine disrupting properties or isidentified to have endocrine disrupting properties in accordance with the criteria set out inCommission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.
Other information
The product has not been tested. The statements on toxicology have been derived from the propertiesof the individual components.
12. Ecological information
Toxicity

There is a high probability that the product is not acutely harmful to aquatic organisms. The inhibitionof the degradation activity of activated sludge is not anticipated when introduced to biologicaltreatment plants in appropriate low concentrations. The product has not been tested. The statementhas been derived from the properties of the individual components

Persistence and degradability

Biodegradable

Bioaccumulative potential

Accumulation in organisms is not to be expected.

Mobility in soil

Adsorption in soil: No data available.

Results of PBT and vPvB assessment

According to Annex XIII of Regulation (EC) No.1907/2006 concerning the Registration, Evaluation,Authorization and Restriction of Chemicals (REACH): The product does not contain a substancefulfilling the PBT (persistent/bioaccumulative/toxic) criteria or the vPvB (very persistent/verybioaccumulative) criteria. Self-classification

Endocrine disrupting properties

Product does not contain a substance above legal limits included in the list established in accordancewith Article 59(1) of Regulation (EC) No 1907/2006 for having endocrine disrupting properties or isidentified to have endocrine disrupting properties in accordance with the criteria set out in CommissionDelegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.

Other adverse effects

The product does not contain substances that are listed in Regulation (EC) 1005/2009 on substancesthat deplete the ozone layer.

13. Disposal considerations
Waste treatment methods

Observe national and local legal requirements.

Contaminated packaging:
Uncontaminated packaging can be re-used.
Packs that cannot be cleaned should be disposed of in the same manner as the contents

14. Transport information
UN number
ADR/RID: -
IMDG: -
IATA: -
UN proper shipping name
ADR/RID:
Not dangerous goods
IMDG:
Not dangerous goods
IATA:
Not dangerous goods
Transport hazard class(es)
ADR/RID: -
IMDG: -
IATA: -
Packaging group
ADR/RID: -
IMDG: -
IATA: -
Environmental hazards
ADR/RID: no
IMDG Marine pollutant: no
IATA: no
Special precautions for user

No data available

15. Regulatory information
Safety, health and environmental regulations/legislation specific for the substance or mixture

Generic authorizations of Novel Foods:
Authorizations are no longer individual. Instead, authorized novel foods are added to the EU list, which serves as a so-called ‘positive list’. Every food business operator that complies with the conditions ofthe authorization can place the respective novel food on the market. Also the applicant-specific novel food authorizations under the old Regulation have been included in the European Union list. This led to an initial list containing 125 entries (numbers as mentioned on the website of the European Commission).

16. Other information

Any other intended applications should be discussed with the manufacturer.

Abbreviations

ADR = The European Agreement concerning the International Carriage of Dangerous Goods by Road. ADN = The European Agreement concerning the International Carriage of Dangerous Goods by Inland waterways. ATE = Acute Toxicity Estimates. CAO = Cargo Aircraft Only. CAS = Chemical Abstract Service. CLP = Classification, Labelling and Packaging of substances and mixtures. DIN = German national organization for standardization. DNEL = Derived No Effect Level. EC50 = Effective concentration median for 50% of the population. EC = European Community. EN = European Standards. IARC =International Agency for Research on Cancer. IATA = International Air Transport Association. IBC-Code= Intermediate Bulk Container code. IMDG = International Maritime Dangerous Goods Code. ISO =International Organization for Standardization. STEL = Short-Term Exposure Limit. LC50 = Lethal concentration median for 50% of the population. LD50 = Lethal dose median for 50% of the population. TLV = Threshold Limit Value. MARPOL = The International Convention for the Prevention of Pollution from Ships. NEN = Dutch Norm. NOEC = No Observed Effect Concentration. OEL = Occupational Exposure Limit. OECD = Organization for Economic Cooperation and Development. PBT = Persistent, Bioaccumulative and Toxic. PNEC = Predicted No Effect Level. PPM = Parts per million. RID = The European Agreement concerning the International Carriage of Dangerous Goods by Rail. TWA = Time Weight Average. UN-number = UN number at transport. vPvB = very Persistent and very Bioaccumulative.

Further information

The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide.
The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions.
It does not represent any guarantee of the properties of other product. VitaSynth shall not be held liable for any damage resulting from handling or from contact with the above product.

16. Attachments
FDA/ CGMP STATEMENT

To whom it may concern,

We hereby confirm our various Menaquinone-7 products has been shipped to USA market under FDA supervision for several years. As a result, our Menaquinone-7 dilutions preparation site (sister company):

Europharma Alliance sp. z o. o.AL. LED 1, 55-020 Rzeplin, Poland

has been audited by FDA on 9th and 10th of October, 2019. It was a comprehensive surveillance inspection of foreign dietary supplement raw material manufacturer conducted in accordance with PAC0314, CGMP/Limited Scope PCHF Inspections, with Operation ID 126761. This inspection covered manufacturing of Vitamin K2 bulk premix as dietary ingredient requiring further processing. Inspection of raw ingredient/material receiving, quarantine, batch production, master manufacturing records, sanitation, quality and complaints produced 0 FDA 483 Inspectional Observations. No complaints regarding the firm were found in FACTS. FDA “closed” inspection under 21 CFR 20.64(d)(3).

Yours faithfully,

Name: Elżbieta Filutowska
Designation: Quality Department

NON-GMO STATEMENT

To whom it may concern,

VitaSynth sp. z o. o. takes every precaution to manufacture and provide safe and functional product range under the trademark: Pharmaquinone®, Vitamin K2 as MK-7 used in the food and chemical industry.

To the best of our knowledge, the product listed above is not derived from genetically modified starting raw materials, or additives that are derived from genetically modified organisms, and do not contain detectable levels of genetically modified materials (known as PCR negative) in compliance with EU Regulation No 1829/2003, including amended EU Directive 2001/18/EC.

Yours faithfully,

Name: Elżbieta Filutowska
Designation: Quality Department

BST/BSE FREE STATEMENT

To whom it may concern,

VitaSynth sp. z o. o. takes every precaution to manufacture and provide safe and functional product range under the trademark: Pharmaquinone®, Vitamin K2 as MK-7 used in the food and chemical industry.

The manufacturing process does not use any ingredient of animal origin nor do our products come in contact with animal products during storage and transportation. To the best of our knowledge, the product listed above is free from Transmissible Spongiform Encephalopathy (TSE) and Bovine Spongiform Encephalopathy (BSE) in compliance with good manufacturing practice and EU Regulation (EC) No 999/2001.

Yours faithfully,

Name: Elżbieta Filutowska
Designation: Quality Department

FAQ
Europharma logo
1. What is MOQ?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

2. What's the shipping time?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

1. What transportation methods does our company have?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

4. Can you supply the free sample?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

5. Does our company support third party testing?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Download all documents
Download package of our documents about this product
Download separate files:
1. Product Information Data Sheet

Click to see online safe pdf

2. Certificate of analysis

Click to see online safe pdf

3. Product specification

Click to see online safe pdf

4. Vitaquinone Leaflet

Click to see online safe pdf

Customers also viewed

Follow the revolution

We send out a monthly industry press releases and our reports. You'll be kept up to date with one mail per month.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaquinone logo
Manufacturer: VitaSynth Sp. z o.o. ul. Szałwiowa 2, 03-167 Warsaw, Poland
Dilutions site: EuroPharma Alliance Sp. z o.o. Aleja Led 1, 55-020 Rzeplin, Poland
FDA logotype
Industry standard
Thanks to your interest in our samples, they have become free.
pharmaquinone.com/freesamples
close button